Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

A Retrospective Chart Review of Patients Treated With Ocriplasmin for Symptomatic VMA

ClinicalTrials.gov ID: NCT02193945

Public ClinicalTrials.gov record NCT02193945. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

OZONE: Ocriplasmin Ellipsoid Zone Retrospective Data Collection Study

Study identification

NCT ID
NCT02193945
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
ThromboGenics
Industry
Enrollment
134 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2014
Primary completion
Apr 30, 2015
Completion
Apr 30, 2015
Last update posted
Jul 8, 2015

2014 – 2015

United States locations

U.S. sites
24
U.S. states
17
U.S. cities
23
Facility City State ZIP Site status
Retinal Diagnostic Center Campbell California 95008
Scripps Clinic La Jolla California 92037
Orange County Retina Medical Group Santa Ana California 92705
California Retina Consultants Santa Barbara California 93103
Retina Vitreous Associates of Florida St. Petersburg Florida 33711
Marietta Eye Clinic Marietta Georgia 30060
Rush university medical center-Dept ophthalmology Chicago Illinois 60612
Carle Foundation Hospital Urbana Illinois 61801
Sabates Eye Centers Leawood Kansas 66211
Carl W. Baker Paducah Kentucky 42001
Ophthalmic Consultants of Boston Boston Massachusetts 02114
Harvard Vanguard Medical Associates Boston Massachusetts 02215
Sierra Eye Associates Reno Nevada 89502
Eyesight Ophthalmic Services Portsmouth New Hampshire 03801
MaculaCare New York New York 10021
Duke University Eye Center Durham North Carolina 27710
Wills Eye Institute Philadelphia Pennsylvania 19107
Black Hills Regional Eye Institute Rapid City South Dakota 57701
Southeastern Retina Associates, P.C. Kingsport Tennessee 37660
Retina Consultants of Houston Houston Texas 77030
Valley Retina Institute, PA McAllen Texas 78503
Retina Specialists Plano Texas 75075
Retina Associates of Utah, P.C. Salt Lake City Utah 84107
West Virginia University Eye Institute Morgantown West Virginia 26506

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02193945, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 8, 2015 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02193945 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →